UHS:NYE-Universal Health Services Inc (USD)

COMMON STOCK | Medical Care Facilities |

Last Closing

USD 181.22

Change

+0.50 (+0.28)%

Market Cap

USD 11.60B

Volume

0.13M

Analyst Target

USD 129.60
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. It also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-24 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap
HCA HCA Holdings Inc

+1.10 (+0.36%)

USD 76.91B
DVA DaVita HealthCare Partners Inc

+2.04 (+1.33%)

USD 13.14B
THC Tenet Healthcare Corporation

+0.07 (+0.05%)

USD 12.31B
EHC Encompass Health Corp

-0.02 (-0.02%)

USD 9.52B
CHE Chemed Corp

+2.43 (+0.47%)

USD 7.84B
CON Concentra Group Holdings Paren..

+0.18 (+0.89%)

USD 2.93B
ARDT Ardent Health Partners, Inc.

+0.17 (+1.07%)

USD 2.59B
NHC National HealthCare Corporatio..

+0.34 (+0.31%)

USD 1.90B
BKD Brookdale Senior Living Inc

-0.04 (-0.78%)

USD 1.11B
AMN AMN Healthcare Services Inc

+0.18 (+0.78%)

USD 1.00B

ETFs Containing UHS

XLVE:CA 1.94 % 0.00 %

N/A

N/A
JPGL:SW JPM Global Equity Multi-F.. 0.35 % 0.00 %

N/A

N/A
JPGL:F JPmorgan ETFs Ireland Ica.. 0.00 % 0.00 %

N/A

USD 0.22B

Market Performance

  Market Performance vs. Industry/Classification (Medical Care Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 18.88% 61% D- 76% C+
Dividend Return 0.39% 20% F 4% F
Total Return 19.27% 61% D- 72% C
Trailing 12 Months  
Capital Gain 17.58% 65% D 75% C
Dividend Return 0.39% 20% F 4% F
Total Return 17.97% 61% D- 71% C-
Trailing 5 Years  
Capital Gain 26.87% 61% D- 64% D
Dividend Return 2.24% 25% F 6% D-
Total Return 29.11% 61% D- 55% F
Average Annual (5 Year Horizon)  
Capital Gain 12.89% 48% F 71% C-
Dividend Return 13.41% 48% F 67% D+
Total Return 0.52% 30% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 30.95% 74% C 34% F
Risk Adjusted Return 43.33% 70% C- 58% F
Market Capitalization 11.60B 86% B+ 87% B+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.